Lupin divests US Commercial Women Health Specialty Business to Evofem Biosciences for nearly USD 84 million Ruchika Sharma16 July 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem...
Lupin Solosec gets USFDA nod to treat trichomoniasis, bacterial vaginosis in adolscents Ruchika Sharma18 Feb 2022 11:55 AM ISTSOLOSEC is the single-dose therapy for oral use.
Lupin gets USFDA nod to expand Solosec use for Trichomoniasis Ruchika Sharma2 July 2021 1:00 PM ISTBaltimore: Pharma major, Lupin Pharmaceuticals, has recently announced that the U.S. Food and Drug Administration (FDA) has approved the company's...
FDA approves secnidazole for treatment of trichomoniasis in adults Dr. Kamal Kant Kohli2 July 2021 9:02 AM ISTThe U.S Food and drug administration (FDA) has approved an expanded indication for SOLOSEC (secnidazole) to include the treatment of trichomoniasis in...
Single oral dose of secnidazole leads to higher cure rates in trichomoniasis: Study Dr Satabdi Saha12 April 2021 10:00 PM ISTTrichomoniasis is the most prevalent non-viral sexually transmitted infection (STI) worldwide, affecting 3.7 million people in the United States....
Lupin inks pact with Phil for bacterial vaginosis drug Solosec Ruchika Sharma3 Feb 2021 12:11 PM ISTSolosec is designed to be a single dose treatment for patients with bacterial vaginosis.
Lupin's supplemental new drug application for Solosec accepted by USFDA Ruchika Sharma17 Nov 2020 1:30 PM ISTMumbai and Baltimore: Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of Lupin Limited, has recently announced that the U.S. Food...
Lupin presents Phase 3 data for Solosec in female trichomoniasis patients Ruchika Sharma17 Aug 2020 1:03 PM ISTMumbai: Pharma major Lupin Pharmaceuticals Inc the US-based wholly-owned subsidiary of Lupin Limited on Saturday announced results from its...
Lupin Announces Positive Topline Results From its Phase 3 Study of Single-Dose Solosec® (secnidazole) in Trichomoniasis Ruchika Sharma4 May 2020 5:54 PM ISTSolosec® is approved by the FDA to treat bacterial vaginosis (BV) in adult women.
Lupin's SOLOSEC gets prefered status in US formulary Ruchika Sharma24 April 2020 3:29 PM ISTSolosec® is the only single 2g oral dose therapy for the most common vaginal infection in the U.S. among women of childbearing age.
